Paediatric Imaging Principles

ALARA is an instruction, and instructions are easy to nod at. The reason paediatric CT is treated differently from adult CT is that the harm has been measured directly in children, and a candidate who can quote both the relative and the absolute figures will handle this station far better than one who can only say "minimise radiation".

The direct human evidence. In a British cohort of about 178,000 patients first scanned before age 22, a cumulative red-marrow dose of roughly 30 mGy or more (mean 51 mGy) carried a relative risk of leukaemia of 3.18 compared with under 5 mGy, and cumulative brain doses of 50-74 mGy carried a relative risk of brain tumour of 2.82. An Australian data-linkage study of 10.9 million people, 680,211 of them exposed to CT under age 20, found overall cancer incidence 24% higher in the exposed (IRR 1.24), rising by 0.16 with each additional scan, with risk greater the younger the child at exposure.

Now the other half, which matters just as much in a consent conversation. Those relative risks sit on a very small baseline. The absolute excess in the British data was about one extra leukaemia and one extra brain tumour per 10,000 head CTs within ten years for children under 10; in the Australian cohort, 9.38 excess cancers per 100,000 person-years. A necessary CT still benefits the child — the target is the UNNECESSARY scan, not CT itself. Quoting only the relative risk frightens families out of scans they need; quoting only the absolute risk excuses scanning without thought. Say both.

The most actionable finding is about variation, not volume. Across seven US health systems, effective dose per paediatric CT ranged from 0.03 to 69.2 mSv — a spread of more than a thousandfold for scans doing the same job. Modelling on that data suggested that simply reducing the highest-quartile doses to the median would prevent about 43% of the projected radiation-induced cancers. That reframes ALARA from an attitude into a target: most of the avoidable harm comes from a high-dose minority of scans, so child-sized protocols, scanning only the indicated region, and avoiding multiphase acquisitions are worth more than agonising over whether to scan at all.

State the limits honestly, because the examiner may press. These are observational studies; reverse causation cannot be fully excluded, since a child scanned for a subtle early symptom may already have had the disease that later declares. The projected cancer counts are modelled on linear-no-threshold assumptions rather than observed. And contemporary doses are lower than those in the 1985-2005 era these cohorts studied — which strengthens rather than weakens the case for optimisation.

View larger

Paediatric imaging requires a fundamentally different approach from adult imaging. Three principles underpin all paediatric imaging decisions: (1) radiation safety — children are 3-5 times more radiosensitive than adults and have a longer remaining lifespan for stochastic effects to manifest; (2) the growing skeleton — cartilaginous structures are radiolucent, ossification centres appear sequentially and can mimic pathology, and growth plates create unique injury patterns; (3) clinical context — children cannot reliably describe symptoms, examination findings may be non-specific, and the differential diagnosis for musculoskeletal complaints is different from adults.

Paediatric Imaging Modality Selection

Differential: Normal Variant versus Pathology

The single most common interpretive error in paediatric imaging is mistaking a normal developmental appearance for pathology (or vice versa). Use this differential whenever a finding looks abnormal in a child.

Controversies & Areas of Uncertainty

• Universal versus selective DDH ultrasound screening. Universal Graf ultrasound (used in parts of Europe) detects more dysplasia but increases over-treatment and cost; selective screening (US/UK) may miss some late-presenting cases. No high-quality trial has resolved which strategy improves long-term hip outcomes, so practice remains region-dependent.
• Magnitude of low-dose CT cancer risk. Cohort data (Pearce, Mathews) show dose-response associations, but reverse causation (scanning sicker children) and the validity of the linear-no-threshold model at low doses are debated. The pragmatic consensus is to optimise and justify rather than to refuse necessary CT.
• Routine comparison radiographs of the uninjured limb. Long taught for the elbow, comparison views add radiation and often little value when a structured CRITOE/line analysis is applied; many paediatric centres now reserve them for genuinely equivocal cases.
• Point-of-care ultrasound for fractures. Evidence for USS in occult elbow and for distal forearm fractures is growing but mostly single-centre and operator-dependent; it is an adjunct, not yet a replacement for radiographs in most guidelines.

View larger

Paediatric imaging is governed by convergent international frameworks. The unifying principle worldwide is justification plus optimisation (ALARA/ALARP) under the EURATOM Basic Safety Standards and ICRP recommendations, operationalised through diagnostic reference levels (DRLs) and child-sized protocols.

Global epidemiology and burden. Paediatric CT use rose sharply in the 1990s-2000s then plateaued/declined after the dose-risk evidence emerged (Miglioretti 2013; Mathews 2013). Effective dose per paediatric CT varies more than 1000-fold between scans and institutions, so the dominant driver of population radiation risk is unoptimised technique rather than the number of scans. DDH affects roughly 1-3 per 1000 live births for true dislocation, with higher rates for instability/dysplasia, and is more common in girls, breech presentation, and those with a positive family history — driving the global debate over universal versus selective ultrasound screening.

Registries and audit. There is no single global paediatric imaging registry, but dose audit is registry-like: national DRL surveys (e.g. UK PHE/HPA, US ACR Dose Index Registry, EU EUCLID project) benchmark paediatric doses by age/weight band, and paediatric DRLs are typically 50-70% lower than adult values for the same examination. For DDH and implant-related paediatric work, arthroplasty registries (NJR, AOANJRR, SHAR) inform downstream practice but do not capture screening imaging.

High- versus limited-resource practice. In well-resourced settings, MRI and high-quality ultrasound are widely available, enabling radiation-free pathways (USS-first for DDH and effusion, MRI for physeal/marrow/tumour questions). In limited-resource settings, MRI access, sedation capacity, and trained paediatric sonographers may be scarce, so radiographs and clinical decision rules carry more weight; here the priorities shift to avoiding unnecessary radiographs, using comparison views judiciously, and reserving CT for clearly decisive indications.

View larger